2024-11-19 08:47:34
Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial
Corporate/ 2023-07-24
Actinogen announces first patient treate...

Approximately 5% of Americans suffer from Major Depressive Disorder (MDD),[1]which is commonly associated with "foggy thinking" bu...

Sirnaomics Announces Positive Interim Data from Phase IIb Clinical Trial of STP705 in Adults with Cutaneous Squamous Cell Carcinoma In Situ
Corporate/ 2023-07-24
Sirnaomics Announces Positive Interim Da...

Dose escalation cohort study is evaluating the safety,tolerability and efficacy of various doses of STP705 administered as intralesional inj...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release